23 Feb Tenaya Therapeutics
Faraz Ali, CEO
Oct. 11 | 11:45am | UBC Ballroom
San Francisco, CA
Tenaya Therapeutics is a biotechnology company committed to a bold mission: to discover, develop, and deliver curative therapies that address the underlying drivers of heart disease. Founded by leading cardiovascular scientists from Gladstone Institutes and the University of Texas Southwestern Medical Center, Tenaya is developing therapies for rare genetic cardiovascular disorders, as well as for more prevalent heart conditions, through three distinct but interrelated product platforms: gene therapy, cellular regeneration, and precision medicine.